Clinical trial
Post-Trial Access to ATH434 for Patients With Multiple System Atrophy
NCT07531433 is registered in ClinicalTrials.gov with Alterity Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-Trial Access to ATH434 for Patients With Multiple System Atrophy
- Lead sponsor
- Alterity Therapeutics
- Phase
- Expanded access
- Overall status
- Available
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.